ExodusPoint Capital Management’s Endologix Inc ELGX Stock Holding History

ExodusPoint Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-40,000	Closed	-$290K	–	1791
2019 Q2	$290K	Buy	+40,000	New	+$273K	0.01%	714

Other funds holding ELGX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

ExodusPoint Capital Management's ELGX Position: Q3 2019 in Review

ExodusPoint Capital Management sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 40,000 shares — an estimated $290K sold.

ExodusPoint Capital Management first reported a position in ELGX in Q2 2019 and held it in 1 quarter. The position peaked at $290K in Q2 2019. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

ExodusPoint Capital Management reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
ExodusPoint Capital Management sold 40,000 Endologix Inc shares in Q3 2019, an estimated $290K.
ExodusPoint Capital Management first reported a position in Endologix Inc in Q2 2019 and held it in 1 quarter.
ExodusPoint Capital Management's Endologix Inc position peaked at $290K in Q2 2019.
63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on ExodusPoint Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.